Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 341

1.

Discovery and validation of a biomarker model (preserve) predictive of renal outcomes after liver transplantation.

Levitsky J, Asrani SK, Klintmalm G, Schiano T, Moss A, Chavin K, Miller C, Guo K, Zhao L, Jennings LW, Brown M, Armstrong B, Abecassis M.

Hepatology. 2019 Sep 11. doi: 10.1002/hep.30939. [Epub ahead of print]

PMID:
31509263
2.

Levosimendan In Single Ventricle Heart Failure After Longterm Survival Of A Modified Blalock-Taussig Shunt.

Tavares J, Baptista B, Sarmento P, Gonçalves B, Abecassis M.

Rev Port Cir Cardiotorac Vasc. 2019 Apr-Jun;26(2):147-149.

PMID:
31476817
3.

Prognostic Role of Albumin, Bilirubin, and ALBI Scores: Analysis of 1000 Patients with Hepatocellular Carcinoma Undergoing Radioembolization.

Antkowiak M, Gabr A, Das A, Ali R, Kulik L, Ganger D, Moore C, Abecassis M, Katariya N, Mouli S, Mahalingam D, Lewandowski RJ, Salem R, Riaz A.

Cancers (Basel). 2019 Jun 24;11(6). pii: E879. doi: 10.3390/cancers11060879.

4.

Immunometabolism of Phagocytes and Relationships to Cardiac Repair.

Zhang S, Bories G, Lantz C, Emmons R, Becker A, Liu E, Abecassis MM, Yvan-Charvet L, Thorp EB.

Front Cardiovasc Med. 2019 Apr 11;6:42. doi: 10.3389/fcvm.2019.00042. eCollection 2019. Review.

5.

ARRIGE Arrives: Toward the Responsible Use of Genome Editing.

Montoliu L, Merchant J, Hirsch F, Abecassis M, Jouannet P, Baertschi B, Sarrauste de Menthière C, Chneiweiss H.

CRISPR J. 2018 Apr;1:128-129. doi: 10.1089/crispr.2018.29012.mon. No abstract available.

6.

External Validation of a Pretransplant Biomarker Model (REVERSE) Predictive of Renal Recovery After Liver Transplantation.

Levitsky J, Asrani SK, Abecassis M, Ruiz R, Jennings LW, Klintmalm G.

Hepatology. 2019 Apr 19. doi: 10.1002/hep.30667. [Epub ahead of print]

PMID:
31002431
7.

Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical Practice.

First MR, Peddi VR, Mannon R, Knight R, Marsh CL, Kurian SM, Rice JC, Maluf D, Mandelbrot D, Patel A, David J, Schieve C, Lee D, Lewis P, Friedewald JJ, Abecassis MM, Rose S.

Transplant Proc. 2019 Apr;51(3):729-733. doi: 10.1016/j.transproceed.2018.10.024. Epub 2018 Dec 11.

8.

Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal Function.

Marsh CL, Kurian SM, Rice JC, Whisenant TC, David J, Rose S, Schieve C, Lee D, Case J, Barrick B, Peddi VR, Mannon RB, Knight R, Maluf D, Mandelbrot D, Patel A, Friedewald JJ, Abecassis MM, First MR.

Transplant Proc. 2019 Apr;51(3):722-728. doi: 10.1016/j.transproceed.2019.01.054. Epub 2019 Jan 26.

PMID:
30979456
9.

The Hispanic Paradox in Patients with Liver Cirrhosis: Current Evidence from a Large Regional Retrospective Cohort Study.

Atiemo K, Mazumder NR, Caicedo JC, Ganger D, Gordon E, Montag S, Maddur H, VanWagner LB, Goel S, Kho A, Abecassis M, Zhao L, Ladner D.

Transplantation. 2019 Apr 2. doi: 10.1097/TP.0000000000002733. [Epub ahead of print]

PMID:
30951016
10.

A clinically relevant murine model unmasks a "two-hit" mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant.

Zhang Z, Qiu L, Yan S, Wang JJ, Thomas PM, Kandpal M, Zhao L, Iovane A, Liu XF, Thorp EB, Chen Q, Hummel M, Kanwar YS, Abecassis MM.

Am J Transplant. 2019 Sep;19(9):2421-2433. doi: 10.1111/ajt.15376. Epub 2019 May 14.

PMID:
30947382
11.

Gene expression biomarkers for kidney transplant rejection - The entire landscape.

Friedewald J, Abecassis M, Kurian S.

EBioMedicine. 2019 Apr;42:41. doi: 10.1016/j.ebiom.2019.03.060. Epub 2019 Mar 22. No abstract available.

12.

Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and Validation.

Ali R, Yang Y, Antkowiak M, Gabr A, Mora R, Abouchaleh N, Al Asadi A, Kulik L, Ganger D, Abecassis M, Kataraya N, Mulcahy M, Benson A, Mahalingam D, Thornburg B, Mouli S, Lewandowski RJ, Salem R, Riaz A.

Cardiovasc Intervent Radiol. 2019 May;42(5):700-711. doi: 10.1007/s00270-019-02191-z. Epub 2019 Mar 1.

PMID:
30824946
13.

Clinical implications for the use of a biomarker for subclinical rejection - Conflating arguments cause a disconnection between the premise and the conclusion.

Friedewald J, Abecassis M.

Am J Transplant. 2019 Jul;19(7):2141-2142. doi: 10.1111/ajt.15327. Epub 2019 Mar 18. No abstract available.

PMID:
30809931
14.

Assessment and management of coronary artery disease in kidney and pancreas transplant candidates.

Knapper JT, Raval Z, Harinstein ME, Friedewald JJ, Skaro AI, Abecassis MI, Ali ZA, Gheorghiade M, Flaherty JD.

J Cardiovasc Med (Hagerstown). 2019 Feb;20(2):51-58. doi: 10.2459/JCM.0000000000000742. Review.

PMID:
30540647
15.

Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma.

Gabr A, Abouchaleh N, Ali R, Baker T, Caicedo J, Katariya N, Abecassis M, Riaz A, Lewandowski RJ, Salem R.

J Vasc Interv Radiol. 2018 Nov;29(11):1502-1510.e1. doi: 10.1016/j.jvir.2018.06.027. Epub 2018 Sep 27.

PMID:
30268638
16.

Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant.

Friedewald JJ, Kurian SM, Heilman RL, Whisenant TC, Poggio ED, Marsh C, Baliga P, Odim J, Brown MM, Ikle DN, Armstrong BD, Charette JI, Brietigam SS, Sustento-Reodica N, Zhao L, Kandpal M, Salomon DR, Abecassis MM; Clinical Trials in Organ Transplantation 08 (CTOT-08).

Am J Transplant. 2019 Jan;19(1):98-109. doi: 10.1111/ajt.15011. Epub 2018 Aug 31.

PMID:
29985559
17.

Response to "Shifting the conversation on outcomes reporting".

Peipert JD, Abecassis MMI, Butt Z, Cella D, Ladner DP.

Am J Transplant. 2018 Sep;18(9):2368-2369. doi: 10.1111/ajt.14968. Epub 2018 Jun 28. No abstract available.

18.

Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma.

Lewandowski RJ, Gabr A, Abouchaleh N, Ali R, Al Asadi A, Mora RA, Kulik L, Ganger D, Desai K, Thornburg B, Mouli S, Hickey R, Caicedo JC, Abecassis M, Riaz A, Salem R.

Radiology. 2018 Jun;287(3):1050-1058. doi: 10.1148/radiol.2018171768. Epub 2018 Apr 24.

PMID:
29688155
19.

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK.

Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913. No abstract available.

PMID:
29624699
20.

The "opportunity costs" of kidney transplantation.

Jay CL, Abecassis MM.

Am J Transplant. 2018 May;18(5):1044-1045. doi: 10.1111/ajt.14724. Epub 2018 Apr 6. No abstract available.

21.

Updated follow-up of a tolerance protocol in HLA-identical renal transplant pairs given donor hematopoietic stem cells.

Leventhal JR, Miller J, Mathew JM, Kurian S, Tambur AR, Friedewald J, Charrette J, Abecassis MM.

Hum Immunol. 2018 May;79(5):277-282. doi: 10.1016/j.humimm.2018.01.010. Epub 2018 Feb 1. Review.

22.

Rapid Biolayer Interferometry Measurements of Urinary CXCL9 to Detect Cellular Infiltrates Noninvasively After Kidney Transplantation.

Gandolfini I, Harris C, Abecassis M, Anderson L, Bestard O, Comai G, Cravedi P, Cremaschi E, Duty JA, Florman S, Friedewald J, La Manna G, Maggiore U, Moran T, Piotti G, Purroy C, Jarque M, Nair V, Shapiro R, Reid-Adam J, Heeger PS.

Kidney Int Rep. 2017 Jun 21;2(6):1186-1193. doi: 10.1016/j.ekir.2017.06.010. eCollection 2017 Nov.

23.

Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience.

Salem R, Gabr A, Riaz A, Mora R, Ali R, Abecassis M, Hickey R, Kulik L, Ganger D, Flamm S, Atassi R, Atassi B, Sato K, Benson AB, Mulcahy MF, Abouchaleh N, Asadi AA, Desai K, Thornburg B, Vouche M, Habib A, Caicedo J, Miller FH, Yaghmai V, Kallini JR, Mouli S, Lewandowski RJ.

Hepatology. 2018 Oct;68(4):1429-1440. doi: 10.1002/hep.29691. Epub 2018 Jan 29.

PMID:
29194711
24.

Incidence and Risk Factors of Intracranial Hemorrhage in Liver Transplant Recipients.

Gallagher TK, Thomas KA, Ladner DP, Ganger D, Sorond FA, Prabhakaran S, Abecassis MM, Fryer JP, Liotta EM.

Transplantation. 2018 Mar;102(3):448-453. doi: 10.1097/TP.0000000000002005.

25.

Advantages of a prospective multidisciplinary approach in transcatheter aortic valve implantation: Eight years of experience.

Costa C, Teles RC, Brito J, Neves JP, Gabriel HM, Abecassis M, Ribeiras R, Abecasis J, Nolasco T, Furstenau MDC, Vale N, Tralhão A, Madeira S, Mesquita J, Saraiva C, Calé R, Almeida M, Aleixo A, Mendes M.

Rev Port Cardiol. 2017 Nov;36(11):809-818. doi: 10.1016/j.repc.2016.11.015. Epub 2017 Nov 15. English, Portuguese.

26.

Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort.

Thornburg B, Desai K, Hickey R, Hohlastos E, Kulik L, Ganger D, Baker T, Abecassis M, Caicedo JC, Ladner D, Fryer J, Riaz A, Lewandowski RJ, Salem R.

J Vasc Interv Radiol. 2017 Dec;28(12):1714-1721.e2. doi: 10.1016/j.jvir.2017.08.005. Epub 2017 Oct 17.

PMID:
29050854
27.

Reply.

VanWagner LB, Ning H, Whitsett M, Levitsky J, Uttal S, Wilkins JT, Abecassis MM, Ladner DP, Skaro AI, Lloyd-Jones DM.

Hepatology. 2017 Dec;66(6):2089-2090. doi: 10.1002/hep.29525. Epub 2017 Nov 6. No abstract available.

PMID:
28921593
28.

Survival Analysis of Advanced HCC Treated with Radioembolization: Comparing Impact of Clinical Performance Status Versus Vascular Invasion/Metastases.

Ali R, Gabr A, Abouchaleh N, Al Asadi A, Mora RA, Kulik L, Abecassis M, Riaz A, Salem R, Lewandowski RJ.

Cardiovasc Intervent Radiol. 2018 Feb;41(2):260-269. doi: 10.1007/s00270-017-1791-1. Epub 2017 Sep 6.

PMID:
28879621
29.

Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection.

Ali R, Riaz A, Gabr A, Abouchaleh N, Mora R, Al Asadi A, Caicedo JC, Abecassis M, Katariya N, Maddur H, Kulik L, Lewandowski RJ, Salem R.

Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2195-2202. doi: 10.1007/s00259-017-3792-3. Epub 2017 Aug 15.

PMID:
28812136
30.

Fostering responsible research with genome editing technologies: a European perspective.

Chneiweiss H, Hirsch F, Montoliu L, Müller AM, Fenet S, Abecassis M, Merchant J, Baertschi B, Botbol-Baum M, Houghton JA, Kritikos M, Mifsud J, Bartnik E, Rath J, Druml C, Friedrich B, Carvalho AS, Lanzerath D, Saint-Raymond A.

Transgenic Res. 2017 Oct;26(5):709-713. doi: 10.1007/s11248-017-0028-z. Epub 2017 Jul 20.

31.

Epigenetic regulation of cellular and cytomegalovirus genes during myeloid cell development.

Liu XF, Hummel M, Abecassis M.

Intern Med Rev (Wash D C). 2017 Mar;3(3). doi: 10.18103/imr.v3i3.385.

32.

A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: The CAR-OLT score.

VanWagner LB, Ning H, Whitsett M, Levitsky J, Uttal S, Wilkins JT, Abecassis MM, Ladner DP, Skaro AI, Lloyd-Jones DM.

Hepatology. 2017 Dec;66(6):1968-1979. doi: 10.1002/hep.29329. Epub 2017 Nov 6.

33.

Proteoforms in Peripheral Blood Mononuclear Cells as Novel Rejection Biomarkers in Liver Transplant Recipients.

Toby TK, Abecassis M, Kim K, Thomas PM, Fellers RT, LeDuc RD, Kelleher NL, Demetris J, Levitsky J.

Am J Transplant. 2017 Sep;17(9):2458-2467. doi: 10.1111/ajt.14359. Epub 2017 Jun 27.

34.

Pufferfish mortality associated with novel polar marine toxins in Hawaii.

Work TM, Moeller PD, Beauchesne KR, Dagenais J, Breeden R, Rameyer R, Walsh WJ, Abecassis M, Kobayashi DR, Conway C, Winton J.

Dis Aquat Organ. 2017 Mar 6;123(2):87-99. doi: 10.3354/dao03096.

35.

Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.

Atiemo K, Skaro A, Maddur H, Zhao L, Montag S, VanWagner L, Goel S, Kho A, Ho B, Kang R, Holl JL, Abecassis MM, Levitsky J, Ladner DP.

Am J Transplant. 2017 Sep;17(9):2410-2419. doi: 10.1111/ajt.14239. Epub 2017 Apr 4.

36.

Biomarker Guidelines for High-Dimensional Genomic Studies in Transplantation: Adding Method to the Madness.

Kurian SM, Whisenant T, Mas V, Heilman R, Abecassis M, Salomon DR, Moss A, Kaplan B.

Transplantation. 2017 Mar;101(3):457-463. doi: 10.1097/TP.0000000000001622. No abstract available.

PMID:
28212255
37.

Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction.

OʼConnell PJ, Kuypers DR, Mannon RB, Abecassis M, Chadban SJ, Gill JS, Murphy B, Nickerson PW, Schold JD, Stock PG, Seron D, Alloway RR, Bromberg JS, Budde K, Jordan SC, Legendre C, Lefaucheur C, Sarwall M, Segev DL, Stegall MD, Tullius SG, Wong G, Woodle ES, Ascher N, Morris RE.

Transplantation. 2017 Jul;101(7):1527-1534. doi: 10.1097/TP.0000000000001648.

PMID:
28207630
38.

Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and Platform.

Kurian SM, Velazquez E, Thompson R, Whisenant T, Rose S, Riley N, Harrison F, Gelbart T, Friedewald JJ, Charette J, Brietigam S, Peysakhovich J, First MR, Abecassis MM, Salomon DR.

Am J Transplant. 2017 Aug;17(8):2103-2116. doi: 10.1111/ajt.14224. Epub 2017 Apr 3.

39.

AASLD guidelines for the treatment of hepatocellular carcinoma.

Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA.

Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086. No abstract available.

PMID:
28130846
40.

Caveat emptor: the devil is still in the detail.

Abecassis M, Kaplan B.

Nat Rev Nephrol. 2017 Jan;13(1):60. doi: 10.1038/nrneph.2016.161. Epub 2016 Nov 14. No abstract available.

PMID:
27840419
41.

Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.

Salem R, Gordon AC, Mouli S, Hickey R, Kallini J, Gabr A, Mulcahy MF, Baker T, Abecassis M, Miller FH, Yaghmai V, Sato K, Desai K, Thornburg B, Benson AB, Rademaker A, Ganger D, Kulik L, Lewandowski RJ.

Gastroenterology. 2016 Dec;151(6):1155-1163.e2. doi: 10.1053/j.gastro.2016.08.029. Epub 2016 Aug 27.

42.

Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients.

Levitsky J, Goldberg D, Smith AR, Mansfield SA, Gillespie BW, Merion RM, Lok AS, Levy G, Kulik L, Abecassis M, Shaked A.

Clin Gastroenterol Hepatol. 2017 Apr;15(4):584-593.e2. doi: 10.1016/j.cgh.2016.07.035. Epub 2016 Aug 25.

43.

The impact of coronary artery disease on outcomes after liver transplantation.

Skaro AI, Gallon LG, Lyuksemburg V, Jay CL, Zhao L, Ladner DP, VanWagner LB, De Wolf AM, Flaherty JD, Levitsky J, Abecassis MM, Gheorghiade M.

J Cardiovasc Med (Hagerstown). 2016 Dec;17(12):875-885.

PMID:
25517876
44.

Exome Sequencing and Prediction of Long-Term Kidney Allograft Function.

Mesnard L, Muthukumar T, Burbach M, Li C, Shang H, Dadhania D, Lee JR, Sharma VK, Xiang J, Suberbielle C, Carmagnat M, Ouali N, Rondeau E, Friedewald JJ, Abecassis MM, Suthanthiran M, Campagne F.

PLoS Comput Biol. 2016 Sep 29;12(9):e1005088. doi: 10.1371/journal.pcbi.1005088. eCollection 2016 Sep.

45.

Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies.

Modena BD, Milam R, Harrison F, Cheeseman JA, Abecassis MM, Friedewald JJ, Kirk AD, Salomon DR.

Am J Transplant. 2017 Mar;17(3):712-723. doi: 10.1111/ajt.14038. Epub 2016 Oct 11.

46.

Hispanic/Latino Disparities in Living Donor Kidney Transplantation: Role of a Culturally Competent Transplant Program.

Gordon EJ, Lee J, Kang R, Ladner DP, Skaro AI, Holl JL, French DD, Abecassis MM, Caicedo JC.

Transplant Direct. 2015 Sep 22;1(8):e29. doi: 10.1097/TXD.0000000000000540. eCollection 2015 Sep.

47.

Medication understanding, non-adherence, and clinical outcomes among adult kidney transplant recipients.

Patzer RE, Serper M, Reese PP, Przytula K, Koval R, Ladner DP, Levitsky JM, Abecassis MM, Wolf MS.

Clin Transplant. 2016 Oct;30(10):1294-1305. doi: 10.1111/ctr.12821. Epub 2016 Aug 29.

48.

Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.

Wang B, Jakus AE, Baptista PM, Soker S, Soto-Gutierrez A, Abecassis MM, Shah RN, Wertheim JA.

Stem Cells Transl Med. 2016 Sep;5(9):1257-67. doi: 10.5966/sctm.2015-0235. Epub 2016 Jul 15.

49.

[Formula: see text]Parent rating of executive function in fetal alcohol spectrum disorder: A review of the literature and new data on Aboriginal Canadian children.

Rai JK, Abecassis M, Casey JE, Flaro L, Erdodi LA, Roth RM.

Child Neuropsychol. 2017 Aug;23(6):713-732. doi: 10.1080/09297049.2016.1191628. Epub 2016 Jun 10. Review.

PMID:
27282764
50.

Mechanical Thrombectomy for Stroke After Cardiac Surgery.

Madeira M, Martins C, Koukoulis G, Marques M, Reis J, Abecassis M.

J Card Surg. 2016 Aug;31(8):517-20. doi: 10.1111/jocs.12776. Epub 2016 Jun 10. Review.

PMID:
27282492

Supplemental Content

Loading ...
Support Center